NCT03820479

Brief Summary

SYNOPSIS Title: An observational study to investigate Quality of Recovery and the incidence and impact of Post-Operative Nausea and Vomiting (PONV)/Post-Discharge Nausea and Vomiting (PDNV) and up to 7 days in females undergoing laparoscopic abdominal surgery provided Apfel-score based PONV care and prophylaxis. Study period: September 2018- September 2019 Hypothesis: When a high risk patient, Apfel-score 3 or 4, is given Apfel-score based PONV care with strict adherence to PONV guidelines there should be no difference in Quality of Recovery between a high-risk patient and a low-risk patient. Aim: The aim of the study is to investigate if it is possible to reach no difference in Quality of Recovery (QoR) between a high-risk patient and a low risk patient using Apfel-score based PONV care. Primary objective: Assessing Quality of Recovery, using QoR15 at 24h, 48h, 72h and after 7 days. Secondary objectives: Assessing the incidence and severity of PONV and PDNV in females undergoing laparoscopic surgery up to 72h. Assessing PONV and PDNV severity and duration. Nicotine habits and impact on PONV. Study outline: Females scheduled for elective abdominal laparoscopic surgery will be provided PONV care based on Apfel risk-score. All patients will fill in the QoR15 form before surgery (base line). PONV and PDNV will be assessed in the PACU postoperatively, after 24h, 48h and 72h. Quality of Recovery will be assessed up to 7 days after surgery. Treatment: The females will be given ordinary care after local routines, with strict adherence to PONV guidelines. Study population: 100 females aged 18-65, ASA 1-2, undergoing laparoscopic abdominal surgery in Danderyds Hospital. Primary outcome variables and examinations: When the QoR 15 reaches base line or better after surgery. Number of times the females experience nausea, retching or vomiting and the impact of emetic symptoms on the QoR.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 29, 2019

Completed
13 days until next milestone

Study Start

First participant enrolled

February 11, 2019

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2024

Completed
Last Updated

July 10, 2025

Status Verified

October 1, 2024

Enrollment Period

5 years

First QC Date

January 23, 2019

Last Update Submit

July 9, 2025

Conditions

Keywords

Quality of recoveryPONVPDNV

Outcome Measures

Primary Outcomes (1)

  • Quality of recovery, QoR15 (Quality of Recovery 15)

    Score, a valid questionnaire to measure quality of recovery, 15 questions, maximum score 150p. VAS scales for each items; 0 bad score, 10 optimal score. Mean values for group, sum score will be compared with parametric tests.

    7 days

Study Arms (4)

Apfel score 1

Female

Other: Protocol

Apfel score 2

Female, non smoker

Other: Protocol

Apfel score 3

Female, non smoker, under 40 years old

Other: Protocol

Apfel score 4

Female, non smoker, under 40 years old, previous history of PONV

Other: Protocol

Interventions

Best practice of protocol

Apfel score 1Apfel score 2Apfel score 3Apfel score 4

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female undergoing laparoscopic surgery

You may qualify if:

  • ASA class 1-2

You may not qualify if:

  • ASA 4, obese

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Danderyds Sjukhus

Stockholm, Sweden

Location

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

Clinical Protocols

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Intervention Hierarchy (Ancestors)

TherapeuticsEpidemiologic Study CharacteristicsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 23, 2019

First Posted

January 29, 2019

Study Start

February 11, 2019

Primary Completion

February 28, 2024

Study Completion

May 15, 2024

Last Updated

July 10, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations